Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$28.38 +0.99 (+3.63%)
At close: Nov 11, 2026 · 4:00 PM EST

Arcutis Biotherapeutics (ARQT) Cash & Current Investments (2018 - 2026)

Updated

Arcutis Biotherapeutics (ARQT) recorded Cash & Current Investments of $204.43 million in Q2 2026, up 73.1% from $118.08 million a year earlier and up 8.0% from the prior quarter.

Analysis

Arcutis Biotherapeutics (ARQT) Cash & Current Investments (2018 - 2026) Analysis & Trends

At the end of FY2025, Arcutis Biotherapeutics reported Cash & Current Investments of $178.08 million, up 13.7% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of -8.9% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $156.62 million in FY2024 (-14.6%), $183.46 million in FY2023 (-55.2%), $409.59 million in FY2022 (+5.8%) and $387.06 million in FY2021 (+36.1%).
  • The Q2 2026 figure is the highest quarterly Cash & Current Investments since Q2 2024.
  • On a year-over-year basis, Cash & Current Investments has increased for three consecutive quarters, with an average decline of 3.4% over the last eight quarters.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 93.6% in Q3 2021, against a decline of 57.5% in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $189.24 million (Q1 2026), $178.08 million (Q4 2025) and $143.95 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.23 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 505.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 8.17 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 14.27 Bn
10 Arcutis Biotherapeutics 3.45 Bn 2.51 Bn 131.46 Mn 259.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 259.46 Mn
Jun 30, 2026 238.55 Mn
Mar 31, 2026 224.00 Mn
Dec 31, 2025 220.98 Mn
Sep 30, 2025 191.07 Mn
Jun 30, 2025 190.82 Mn
Mar 31, 2025 198.09 Mn
Dec 31, 2024 227.96 Mn
Sep 30, 2024 330.56 Mn
Jun 30, 2024 362.44 Mn
Mar 31, 2024 403.87 Mn
Dec 31, 2023 271.86 Mn
Sep 30, 2023 227.11 Mn
Jun 30, 2023 268.67 Mn
Mar 31, 2023 332.41 Mn
Dec 31, 2022 409.59 Mn
Sep 30, 2022 476.96 Mn
Jun 30, 2022 282.17 Mn
Mar 31, 2022 343.60 Mn
Dec 31, 2021 387.06 Mn
API Access

Arcutis Biotherapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ARQT&period=max&api_key=YOUR_API_KEY